CASES SHOW

505(b)(2) Lyophilized Microspheres Accept FDA PAI Inspection (“Zero deficiency”)

Case Two


505(b)(2) Lyophilized Microspheres Accept FDA PAI Inspection (“Zero deficiency”)

KRB GMP team provided consulting services for a company's lyophilized microspheres to prepare and pass for FDA pre-approval inspection. The consulting services included gap analysis, hardware renovation guidance, re-validation consulting, personnel training, system optimization and enhancement, and technical support during the inspection. This product has a very complex sterilized management including sterilized lyophilization, sterilized powder dispensing, non-terminal sterilization pre-filled syringe and other technologies. Finally this project pass FDA PAI without deficiency which is also the first Chinese 505(b)(2) sterilized preparation pass FDA inspection.


CASES SHOW

CONTACT

Phone number

Phone number:400-0123-669

Address

Address:A805, Tower A, Chaowai SOHO, 6B Chaowai Street, Chaoyang District, Beijing 100020

KRB Consulting

Wechat account

Search for “KRB Consulting”

to know more!

Copyright © 2023 KRB CONSULTING  All Rights Reserved.    300.cn TAG  Business License